Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|October 18, 2018
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation setElizabeth Hope Cain, Ashirbani Saha, Michael R Harowicz, et al.
Gynecologic Oncology|January 22, 2005
High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancerRobyn A Sayer, Johnathan M Lancaster, Jennifer Pittman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancersWilliam J Lowery, Joellen M Schildkraut, Liudmila Akushevich, et al.
Molecular Cancer Research : MCR|February 12, 2009
Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapyHisani N Horne, Paula S Lee, Susan K Murphy, et al.
BMC Cancer|May 30, 2009
Do serum biomarkers really measure breast cancer?Jonathan L Jesneck, Sayan Mukherjee, Zoya Yurkovetsky, et al.
Breast Cancer Research : BCR|June 16, 2011
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypesMichael L Gatza, Hsiu-Ni Kung, Kimberly L Blackwell, et al.
Eukaryotic Cell|April 13, 2004
Cell cycle progression in G1 and S phases is CCR4 dependent following ionizing radiation or replication stress in Saccharomyces cerevisiaeTammy J Westmoreland, Jeffrey R Marks, John A Olson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2013
Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factorsJoellen M Schildkraut, Edwin S Iversen, Lucy Akushevich, et al.
Cancer Research|April 19, 2006
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progressionJun Yao, Stanislawa Weremowicz, Bin Feng, et al.
American Journal of Obstetrics and Gynecology|May 1, 2004
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarraysAndrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
Pageof 15